How many CJC-1295 clinical trials are indexed?

1 unique studies in the current PeptideStat snapshot. The source query returned 1 registry matches; high-volume queries are capped at the most recently updated 75 records before cross-query deduplication.

Are any CJC-1295 trials recruiting?

0 indexed studies currently carry a recruiting status. Always confirm the current status and site contacts on the source registry record.

What is the highest phase for CJC-1295?

Phase 2 is the highest phase label among indexed studies. Phase labels can overlap and some observational studies are not assigned a phase.

Do registered trials prove that CJC-1295 works?

No. Registration shows that a study record exists. Conclusions require completed results, appropriate study design, peer-reviewed evidence and regulatory context.

Evidence dashboardStudies since 2005Updated Jul 31, 2026

CJC-1295Clinical Trials.

A source-linked view of every CJC-1295 study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.

Total trials: 1
Recruiting: 0
Completed: 0
Terminated: 1
Results posted: 0
Average enrollment: 120
Countries: 0
Highest phase: Phase 2

Largest indexed study

120 participants · NCT00267527 →

Developer / research origin

ConjuChem

Evidence summary

Activity is not efficacy.

CJC-1295 appears in 1 indexed studies: 0 recruiting, 0 completed and 0 with registry results posted. The highest registered development stage in this snapshot is Phase 2. These counts measure registry activity; they do not establish that CJC-1295 is safe or effective.

Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.

Development history

Trial timeline.

Evidence timeline

2005—2005

2005

Velocity

CJC-1295 studies by start year

Study start year · indexed snapshot

Development

Trials by phase

1phase labels

Early Phase 10

Phase 10

Phase 21

Phase 30

Phase 40

Current studies

Recruiting or active

Completed studies

Finished records

Stopped studies

Withdrawn or terminated

No studies in this snapshot.

NCT IDStudyPhase / statusEnrollmentUpdated

NCT00267527

A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity

ConjuChem · Obesity · HIV Infections

Phase 2

Terminated

120

2006-10

Full study index

Search CJC-1295 trials.

Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.

1 matching study

Last registry update first

NCT00267527Phase 2

A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity

CJC-1295ConjuChemObesity · HIV Infections

Terminated

Enrollment: 120
Started: Dec 2005
Completion: Sep 2006
Locations: 0
Countries: 0
Updated: Oct 2006

End of 1 results

Latest publications

Follow the paper trail.

No PMID-linked publications are present in the indexed registry records for this molecule.

Keep researching CJC-1295.

Commercial research listings, where present, are kept separate from clinical evidence and are not treatment recommendations.

DatabaseCJC-1295 database page →Market comparisonCJC-1295 research listings →Lab reportsSearch the COA ledger →Research vendor recordAscension Peptides →Research vendor recordIon Peptide →Research vendor recordGlacier Aminos →Research vendor recordNOVA Labs →Source registrySearch ClinicalTrials.gov ↗